Secukinumab Provides Sustained Improvements in the Signs and Symptoms of Active Psoriatic Arthritis: 3-Year Results from the Phase 3 Future 2 Study

Authors

P Nash
I McInnes
P Rahman
Alice B. Gottlieb, New York Medical CollegeFollow
B Kirkham
K Ding
L Pricop
Future 2 Study Grp

Author Type(s)

Faculty

Document Type

Abstract

Publication Date

6-2018

Journal Title

Annals of Rhuematic Diseases

Department

Medicine

Recommended Citation

Nash, P., McInnes, I., Rahman, P., Gottlieb, A. B., Kirkham, B., Ding, K., Pricop, L., & Future 2 Study Grp. (2018). Secukinumab Provides Sustained Improvements in the Signs and Symptoms of Active Psoriatic Arthritis: 3-Year Results from the Phase 3 Future 2 Study. Annals of Rhuematic Diseases, 77 (Suppl. 2), 379. Retrieved from https://touroscholar.touro.edu/nymc_fac_abstracts/377